Introduction
============

Tuberculosis (TB) is an ancient disease that has accompanied animals and humans for thousands of years. Globally, it is estimated that TB has killed 1 billion people in the past 200 years, which turns it as the biggest killer compared with other infectious diseases as plague, influenza, smallpox, malaria, cholera, or AIDS among others ([@evw279-B42]). TB is responsible for 1.8 million deaths each year ([@evw279-B63]). The main pathogen causing TB in humans is *Mycobacterium tuberculosis*. Other species such as *M. africanum* and *M. canettii* are also able to infect humans with less pathogenic potential and they are phlylogeographically restricted to certain populations in West- and East-African countries, respectively ([@evw279-B20]; [@evw279-B53]). On the other hand, animal-adapted ecotypes such as *M. bovis* and *M. caprae* infecting cattle and goats, respectively, represent an economic burden as well as a zoonotic risk for humans ([@evw279-B3]; [@evw279-B51]; [@evw279-B19]). Several studies have addressed the phylogenetic classification of TB-causing mycobacteria. Pioneering works based on comparative genomics demonstrated that *Mycobacterium* species evolved by irreversible loss of genomic regions, which cannot be compensated by horizontal gene transfer. This pattern of reductive evolution led to propose an evolutionary scenario for these species ([@evw279-B8]). Subsequent studies based on whole-genome sequencing confirmed and refined the previous deletion-based phylogeny and proposed the existence of eight major lineages (L1--L7 and animal-adapted species), which include the human-adapted ecotypes *M. tuberculosis* (L1--L4 and L7), *M. africanum* (L5 and L6), and *M. canettii* and the animal-adapted ecotypes *M. bovis*, *M. caprae*, *M. microti*, *M. pinnipedii*, *M. orygis* and *M. mungi* ([@evw279-B14]). With the exception of *M. canettii*, considered an ancestral lineage from which the remaining species emerged, these lineages comprise the *M. tuberculosis* complex (MTBC).

Despite the MTBC is strictly clonal and it is characterized by less than 0.05% sequence divergence between lineages, for a 4 Mb genome, this value is readily translated into 2000 polymorphisms per genome ([@evw279-B8]; [@evw279-B14]). Considering that MTBC species code for roughly 4000 genes, this means that half of the genes might be virtually affected by polymorphisms. Even if a number of these variations might represent silent mutations or affect non-coding sequences, it is tempting to speculate that some missense or nonsense mutations might determine lineage-specific phenotypes or even impact on the host range of human- and animal-adapted species.

It is well known that Beijing-L2 strains are associated with a massive spread of drug resistance in Europe and Asia and this phenotype appear to be related with positive selection of single nucleotide polymorphisms in selected genes ([@evw279-B36]). A comparative study of the mutation rate between some L2 and L4 strains suggest that acquisition of drug resistance in Beijing-L2 strains might be related to the higher basal mutation rate of this lineage ([@evw279-B25]). However, the specific polymorphism(s) underlying Beijing-L2 phenotypes are poorly understood. In this same line, it is still unknown why *M. africanum* L5 and L6 are geographically restricted to West African populations even if it has been recently sequenced the largest genome repertoire of this lineage ([@evw279-B64]). This is also applied to *M. canettii* that is restricted to East African populations but the genetic determinants responsible for its phylogeographic preference start to be delineated ([@evw279-B53]; [@evw279-B5]; [@evw279-B6]). Another attractive and yet unresolved question is the host-pathogen specificity of the MTBC. It is intriguing how so phylogenetically related bacteria infect a variety of hosts ranging from humans to ungulates, rodents and pinnipeds. Although the answer is hampered due to the relative scarcity of genome sequences from animal-adapted species, recent studies have started to address this issue ([@evw279-B7]; [@evw279-B19]).

Previous genomic studies were predominantly focused on the human pathogen *M. tuberculosis*, mainly due to the scarcity of whole genome sequences from other members of the MTBC. Today, the advent of next generation sequencing has provided the first collection of genomic data from *M. africanum* and animal-adapted species ([@evw279-B19]; [@evw279-B64]). Thus, studies covering the whole MTBC are now possible. On the other hand, irrespective of this cumulative genomic data, studies regarding comparison of the coding sequences in the MTBC are more limited. In particular, investigations concerning the structural and functional implications of single amino acid mutations have been poorly reported. A recent study has proved the value of investigating amino acid polymorphisms to understand the evolution of virulence phenotypes in the MTBC. This work showed that a single amino acid substitution in the PhoPR virulence system from *M. africanum*-L6 and the animal-adapted ecotypes ablates PhoPR function. Consequently, L6 and animal-adapted strains lack acyltrehalose-derived lipids and other PhoPR-dependent phenotypes ([@evw279-B27]). Given the essential role of PhoPR in *M. tuberculosis* virulence ([@evw279-B9]), it is plausible to think that PhoPR polymorphisms have shaped the evolution of the MTBC. Thus, characterizing differences in protein coding sequences between mycobacterial species is expected to reveal yet unexplored virulence features. With this aim we have analyzed in this work 74 complete proteomes from six *Mycobacterium* species including *M. africanum*, *M. bovis*, *M. canettii*, *M. caprae*, *M. orygis* and *M. tuberculosis* ([fig. 1](#evw279-F1){ref-type="fig"}). The effect of sequence variations on the structural and functional features of proteins will be discussed.

![Schematic phylogenetic relationships of the MTBC showing the number of genome sequences analyzed in this work. The figure also shows the phylogenetic distribution of *M. canettii*, the L1--L7 lineages and the animal-adapted species, as well as the geographic distribution of each lineage and the preferred host.](evw279f1p){#evw279-F1}

Materials and Methods
=====================

Mycobacterium Proteome Analysis
-------------------------------

Complete 74 proteomes of 6 Mycobacterial species: *M. tuberculosis* (2 strains), *M. africanum* (28 strains), *M. canettii* NC_015848 (1 strain), *M. bovis* (41 strains), *M. caprae* (1 strain), and *M. orygis* (1 strain) were retrieved from NCBI GenBank (<http://www.ncbi.nlm.nih.gov/>). The strains analyzed include *M. tuberculosis* reference strain H37Rv (NC_000962), *M. tuberculosis* strain *Beijing* (NC_021054), *M. orygis* (112400015), *M. canettii* (NC_015848), *M. caprae* (CDHG01), and the remaining 69 strains listed in [supplementary table S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online.

The determination of the core genome, which encodes 3009 proteins, from these 74 strains was carried out using the bioinformatic tool GET_HOMOLOGUES ([@evw279-B18]) and taking all core genes identified by both the OMCL and the COGS algorithms. The *M. tuberculosis H37Rv* strain was used as reference. Each set of homologous sequences were aligned and mutations were identified using custom Perl scripts, including amino acid substitutions, deletions, and insertions.

Epitope and Functional Cluster Analysis
---------------------------------------

Epitopes were retrieved from ([@evw279-B13]) and following the methods described in [@evw279-B15]. Functional cluster classification was as in Tuberculist (<http://tuberculist.epfl.ch>). Mutations were found using custom Perl scripts.

dN/dS Analyses
--------------

Thirty-four non-redundant genomes from *M. canettii* (1), *M. africanum* (13), *M. bovis* (16), and *M. tuberculosis* (4) were analyzed. Translated CDS sequences of single-copy core clusters were aligned with Clustal-omega v1.2.1 ([@evw279-B50]) and the resulting alignments translated back to codon alignments using the primers4clades suite ([@evw279-B17]). Each codon alignment was then passed to yn00_cds_prealigned, obtained from <https://github.com/hyphaltip/subopt-kaks> ([@evw279-B67]) to estimate the ratio of nonsynonymous substitutions per nonsynonymous site (dN) to the number of synonymous substitutions per synonymous site (dS) of all pairs of pre-aligned sequences. Pairs of identical sequences in each cluster were not considered for dN/dS calculations.

Predictions of Intrinsic Disorder and Molecular Recognition Motifs
------------------------------------------------------------------

DISOPRED v3.1 ([@evw279-B33]) predictions were performed for all protein sequences of the *Mycobacterium* core proteome. All input sequences, plus the reference database uniref90, were low-complexity filtered with PFILT and scanned with three iterations of BLASTPGP with an *E*-value cut-off of 0.001. Predictions in PhoR protein were also done using IUPred and ANCHOR (<http://iupred.enzim.hu>), MoRFPred (<http://biomine-ws.ece.ualberta.ca/MoRFpred/index.html>), and RONN (<https://www.strubi.ox.ac.uk/RONN>).

Prediction of Epitope Binding to HLA Molecules
----------------------------------------------

CD8^+^T and CD4^+^T cell epitope prediction was performed with NetMHCpan 3.0 ([@evw279-B2]) and NetMHCIIpan 3.1 ([@evw279-B1]), respectively, because these tools were considered the best overall predictors in independent benchmarks ([@evw279-B12]; [@evw279-B70]; [@evw279-B55]). Overlapping peptides comprising the amino acid residues of interest were tested for their binding affinity to all available classical HLA class I alleles (HLA-A, HLA-B and HLA-C; *n* = 2,915) and DR locus alleles for class II (*n* = 660) ([supplementary table S4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). These HLA haplogroups were chosen due to higher predictive reliability ([@evw279-B1]) and data availability in the Immune Epitope Database (IEDB) ([@evw279-B61]). In the case of deletions, we predicted all the possible overlapping peptides that were present in the larger and smaller versions of the epitopes. Eight to 14-mers peptides were used in HLA class I predictions and nine to 25-mers in HLA class II. The cut-off for high binding affinity was IC~50~\< 50 nM or rank score \< 0.5%. The fraction of the human population with the ability to recognize the predicted epitopes (population coverage) was estimated using the implementation of a previously described algorithm ([@evw279-B10]) at IEDB (<http://tools.immuneepitope.org/tools/population/iedb_input>).

Results
=======

Comparative Proteome Polymorphism Analysis
------------------------------------------

Analysis of protein sequence variations was done in the group of proteins encoded by the core-genome of *Mycobacterium* species (*M. africanum, M. bovis, M. canettii, M. caprae, M. orygis*, and *M. tuberculosis*), which represents 3009/3645 proteins, *ca.* 82.5%. The *Mycobacterium* proteins encoded by the core-genome are distributed in nine functional classes as follows: virulence, detoxification and adaptation (80/3009 proteins, 2.6%), lipid metabolism (180/3009 proteins, 6.0%); information pathways (217/3009 proteins, 7.2%), cell wall and cell processes (593/3009 proteins, 19.7%), insertion sequences and phages (19/3009 proteins, 0.6%), proline--glutamate (PE), and proline--proline--glutamate (PPE) proteins (55/3009 proteins, 1.8%), intermediary metabolism and respiration (767/3009 proteins, 25.5%), unknown proteins (1/3009 proteins, 0.03%), regulatory proteins (158/3009 proteins, 5.2%), conserved hypothetical proteins (780/3009 proteins, 25.9%), and conserved hypothetical proteins with an ortholog in *M. bovis* (159/3009 proteins, 5.3%) ([fig. 2*A*](#evw279-F2){ref-type="fig"}, right). This distribution is comparable to that of the complete *M. tuberculosis* H37Rv proteome. Analysis of polymorphisms revealed that they affect similarly all functional classes ([fig. 2*A*](#evw279-F2){ref-type="fig"}, left). When the analysis is restricted to the subset of proteins with experimental evidence annotated in BioCyc (*n* = 323), the data reveal a similar trend, with the largest classes, lipid (19--30%) and intermediary metabolism and respiration (15%), harboring most mutations. Statistical analyses did not indicate deviations from the expected distribution of mutations along functional classes ([fig. 2*B*;](#evw279-F2){ref-type="fig"}[supplementary table S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online)*.* These percentages were normalized taking into account the total proteins associated to each functional group and the sequence identity averages.

![(*A*) Overall distribution of proteins encoded by the core-genome of *M. tuberculosis* H37Rv (right panel) and the average mutated proteins found in 74 species of the MTBC analyzed in this work (left panel). Both diagrams are divided according to functional classes. (*B*) Distribution according to functional classes of mutated proteins with experimental evidence annotated in BioCyc of *M. canettii* (dark blue), *M. africanum* (red), *M. bovis* AF2122 (green), *M. tuberculosis* Beijiing (violet), *M. orygis* (ligth blue), and *M. caprae* (orange). Cluster 0, virulence, detoxification and adaptation; cluster 1, lipid metabolism; cluster 2, information pathways; cluster 3, cell wall and cell processes; cluster 5, insertion sequences and phages; cluster 6, proline--glutamate (PE) and proline--proline--glutamate (PPE) proteins; cluster 7, intermediary metabolism and respiration; cluster 8, unknown proteins; cluster 9, regulatory proteins; cluster 10, conserved hypothetical proteins; cluster 16, conserved hypothetical proteins with an orthologue in *M. bovis*. The percentages are normalized taking into account the total proteins associated to each functional group (A) and the sequence identity averages (B).](evw279f2p){#evw279-F2}

Polymorphisms in Protein Disordered/Ductile Regions
---------------------------------------------------

Research of the past decade and a half has provided valuable information about intrinsically disordered/ductile proteins (IDPs) and regions (IDRs) as well as their role in diseases ([@evw279-B59]; [@evw279-B66]). IDPs and IDRs are characterized by a number of specific features that distinguish them from those of ordered proteins and domains and make them predictable ([@evw279-B29]). Such particular structural and biochemical properties of disordered/ductile regions are ideal for proteins that mediate specific molecular recognition and interaction with partners or co-ordinate regulatory events ([@evw279-B57]). Accordingly, ductility and flexibility feature in proteins confers advantages for their functional versatility ([@evw279-B4]). But also variations in protein flexibility can modify protein function and phenotype.

This is the case of the PhoPR two-component virulence system, where the single mutation Gly71Ile found in PhoR from *M. bovis* and *M. africanum* L6 cause strong phenotypic differences ([@evw279-B27]). The Gly71Ile mutation is located within the periplasmic loop of PhoR (Ser36 to Arg155) ([fig. 3*A*](#evw279-F3){ref-type="fig"}). The intrinsically disorder predictions performed in this work show that such mutation reduce the flexibility of the Thr61--Gln91 amino acid segment. Thus, subtle variations in the flexibility of the periplasmic loop can cause a dramatic effect on the protein function and phenotype. The results obtained with IUPred ([@evw279-B21]) and RONN ([@evw279-B68]) are shown in [figure 3*B*](#evw279-F3){ref-type="fig"}. These are similar to those obtained with DISOPRED v3.1 ([@evw279-B33]) ([supplementary fig. S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Moreover, ANCHOR ([@evw279-B22]) and MorRFPred ([@evw279-B37]) point out that Thr61--Gln91 amino acid region in *M. tuberculosis* PhoR could be a molecular recognition motif. Besides, the glycine substitution by the branched-amino acid isoleucine probably impairs ordered-disordered transitions in such protein region of *M. bovis*/*M. africanum* modifying possible molecular interactions ([fig. 3*B*](#evw279-F3){ref-type="fig"}).

![(*A*) Schematic representation of the topology of PhoR. Note the presence of two transmembrane helices spanning the periplasmic loop which contains the Gly71Ile mutation present in *M. africanum* L6 and animal-adapted species. (*B*) Disorder and molecular recognition motif predictions in the 61--121 amino acid segments of the periplasmic sensor loop of PhoR from *M. tuberculosis* and *M. bovis*/*M.africanum* L6. *Y*-axis values ≥ 0.5 means high probability of disorder. Note that the Gly71Ile mutation severely affects the ductility of the sensor domain. Predictions were carried out with IUPred and ANCHOR (left panel, red and blue lines, respectively), MoRFPred (middle panel, red line), and RONN (right panel, red line) (for details see "Materials and Methods" section).](evw279f3p){#evw279-F3}

Taking into account the above results, further analyses were focused to investigate the presence of mutations in disordered/ductile regions (IDRs) of *Mycobacterium* proteomes in order to know their effect on structural and functional protein features. The results derived from DISOPRED v3.1 prediction indicated that disordered residues are present in all protein categories of *M. tuberculosis* being its content higher in antigens compared with essential and non-essential proteins ([fig. 4*A*](#evw279-F4){ref-type="fig"}). Moreover, our results also show that epitopes are preferentially distributed in ordered regions in the MTBC and the higher frequency of disordered regions in antigenic proteins is restricted to non-epitope regions. This finding is agreement with previous investigations ([@evw279-B38]; [@evw279-B43]). Furthermore, *ca.* 14% *M. tuberculosis* H37Rv proteins contain a long disordered segment (L \> 30 aa), which is in agreement with other bacterial proteomes ([fig. 4*B*](#evw279-F4){ref-type="fig"}). It is estimated that archaea and bacteria have 7--30% of such proteins ([@evw279-B44]). The amino acid composition of *M. tuberculosis* IDRs is enriched in methionine and proline ([fig. 4*C*](#evw279-F4){ref-type="fig"}), which are characteristic of IDRs in different organisms ([@evw279-B23]; [@evw279-B69]).

![(*A*) Average distribution of disordered residues in the proteins encoded by the core-genome of *M. tuberculosis*, essential proteins, nonessential proteins, antigens, and epitopes. (*B*) Percentage of intrinsically disordered/ductile proteins (IDPs) encoded by the core-genome of *M. tuberculosis* versus the length of disordered segments. (*C*) Frequency of amino acids within the disordered/ductile segments (L \> 30).](evw279f4p){#evw279-F4}

To know in detail the implications of mutations in ductile regions the attention was focused in well-annotated proteins with longer disordered segments (L \> 30) because these regions are normally associated with high confidence to particular functions ([@evw279-B47]; [@evw279-B41]; [@evw279-B66]). Twenty-one of these well-annotated proteins have mutations along their sequences. Among them only four proteins, Rv2215 (DlaT), Rv2358 (SmtB), Rv2495c (BkdC), and Rv3003c (IlvB1) have mutations inside IDRs ([table 1](#evw279-T1){ref-type="table"}). Interestingly, SmtB of *M. tuberculosis* Beiijing shows five amino acid substitutions in the Phe30--Pro37 motif of the N-terminal in comparison with *M. tuberculosis* H37Rv. The substitutions Ala31Ser, Glu32Thr, Cys33Ala, Thr35Gly, and Phe36Gly are predicted to induce a gain of flexibility in the sequence of *M. tuberculosis* Beijing strain compared with the H37Rv one ([supplementary fig. S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). ANCHOR ([@evw279-B22]) predicted that this mutated region is more probably a molecular recognition motif (MoRF) in the Beijing strain. These variations might affect the function of the N-terminal of this protein. Table 1Proteins of MTBC Species with Mutations in Disordered/Ductile Segments L \> 30 with Respect to *M. tuberculosis* H37RvgeneproteinFNCGenome with MutationIDR L \> 30IDR L \< 30Mutation PositionMoRF (ANCHOR)MoRF (Disopred3.1)Phospho site[^1^](#evw279-TF2){ref-type="table-fn"}Rv3003cIlvB17*M. canetii* (1)1--3786--9235 (L/P)[\*](#evw279-TF1){ref-type="table-fn"}32--451--3nd211--22351--59514--519431608--618515--519608--618Rv2358SmtB9*M. tuberculosis* str. Beijing/(5)1--36nd31 (A/S)[\*](#evw279-TF1){ref-type="table-fn"}1--221--9nd32 (E/T)[\*](#evw279-TF1){ref-type="table-fn"}33 (C/A)[\*](#evw279-TF1){ref-type="table-fn"}35 (T/G)[\*](#evw279-TF1){ref-type="table-fn"}36 (F/G)[\*](#evw279-TF1){ref-type="table-fn"}Rv2215DlaT7*M. canettii* (2, insert)80--119157--159139 (I/T), 210 (insert1--11ndnd200--239287--288APKP)[\*](#evw279-TF1){ref-type="table-fn"}, 265 (G/E)31--4148--91*M. bovis* BCG Pasteur (1)517 (L/V)117---160169--204236--298307--319Rv2495cBkdC7*M. africanum* (1)87--1161--4107 (T/A)[\*](#evw279-TF1){ref-type="table-fn"}23--311--4Ser55[^1^](#evw279-TF2){ref-type="table-fn"}*M. canettii* (2)67 (A/V), 107(T/A)[\*](#evw279-TF1){ref-type="table-fn"}*M. bovis* (2)107 (T/A)[\*](#evw279-TF1){ref-type="table-fn"}, 208 (R/W)*M. tuberculosis* str. Beijing/NITR203 (2)103 (Y/D)[\*](#evw279-TF1){ref-type="table-fn"}, 107 (T/A)[\*](#evw279-TF1){ref-type="table-fn"}*M. orygis* (2)107 (T/A)[\*](#evw279-TF1){ref-type="table-fn"}, 158 (R/G)[^2][^3]

SmtB is a Zn-binding transcription regulator, a member of the ArsR family ([@evw279-B11]), which allows the organism to respond to a wide range of changes in its immediate microenvironment. The SmtB presents homology with the human p53 transcription factor. Particularly, the alignment shows similarity with the TransActivation Domain 2 (TAD2) (residues 40--60), and a proline-rich region, PR (residues 64--92) of its N-terminal ([supplementary fig. S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). It is well known that the N-terminal of p53 is involved in a multitude of interactions with a wide spectrum of partners ([@evw279-B65]). Considering these observations, the amino acid substitutions in the N-terminal of SmtB of *M. tuberculosis* Beijing might perturb the interaction with their partners or to increase their number. The tridimensional structure of SmtB protein is still unknown and there is not information about the possible molecular interactions with their partners. However, structural homologues could provide information about these features and help us to understand the effect of such variations. In this sense, structural models of the SmtB from both *M. tuberculosis* H37Rv and Beijing (*E*-value = 2.2e−14) were produced using the NMR tridimensional structure (pdb 2lkp) of the NmtR transcription factor of *M. tuberculosis* (Rv3744) as template, which is also a member of the ArsR family. The comparison of both SmtB structure models shows relative conformational variations in the N-terminal ([fig. 5](#evw279-F5){ref-type="fig"}).

![Structural models of SmtB transcription factor of *M. tuberculosis* H37Rv (magenta) and *M. tuberculosis* Beijing (light blue) using the NMR structure of NmtR transcription factor of *M. tuberculosis* (pdb 2lkp) as template. The residues of the non-conserved motif Phe30, Ala31, Glu32, Cys33, Thr35, Phe36, Pro37 in *M. tuberculosis* H37Rv and Phe30, Ser31, Thr32, Ala33, Gly35, Gly36, Pro37 in *M. tuberculosis* Beijing are shown in sticks. The three-dimensional cartoons were drawn using PyMol 1.4.1 (Schrodinger LLC).](evw279f5p){#evw279-F5}

Furthermore, Rv2495c, a component of branched-chain alpha-ketoacid dehydrogenase complex (BkdC, UniProt O06159) shows mutations in Tyr103Asp and Thr107Ala in *M. tuberculosis* Beijing compared with *M. tuberculosis* H37Rv which increase the flexibility in this region as indicate IUPred/ANCHOR predictions ([supplementary fig. S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The functional implications for this higher flexibility remain to be elucidated.

Polymorphism Analysis in Human Antigens and T-Cell Epitopes
-----------------------------------------------------------

It is generally well assumed that human antigens containing T-cell epitopes in *M. tuberculosis* are evolutionarily hyperconseved. Accordingly, dN/dS of antigens and epitope regions are lower than dN/dS of essential and non-essential proteins ([@evw279-B13]). However, to the best of our knowledge, the hyperconservation of T-cell epitopes has not been interrogated in other species different from *M. tuberculosis* and BCG vaccines ([@evw279-B15]; [@evw279-B16]; [@evw279-B52]). The overall ratio of nonsynonymous/synonymous substitutions (dN/dS) was calculated for the aligned CDS sequences from MTBC species listed above based on the number of nonredundant synonymous and nonsynonymous changes. Note that for these calculations a subset of 34 nonredundant genomes was analyzed, leaving out those with average peptide identity over 95.3%. The calculated dN/dS values indicated that antigens are evolutionarily conserved to the same extent than essential and nonessential genes ([fig. 6*A*](#evw279-F6){ref-type="fig"}). This result allows expanding the general assumption about hyperconservation of human T-cell epitopes to the whole MTBC.

![(*A*) dN/dS in MTBC species calculated for nonessential genes, essential genes and antigens. Note that antigens present dN/dS ratios comparable to essential and nonessential genes, indicative of antigen hyperconservation in the whole MTBC. (*B*) Localization in the *M. tuberculosis* H37Rv chromosome of T-cell antigens showing one (black dots) or more than one (red dots) polymorphism in the MTBC species analyzed in this work. The inner circle indicates the protein name and gene number according to H37Rv nomenclature. The number of epitopes contained in every antigen is provided in parentheses. The outer circumference contains information about those MTBC species carrying epitope mutations. For detailed information about every polymorphism see [supplementary table S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online.](evw279f6p){#evw279-F6}

However, it should be noted that interrogating the whole MTBC implies a higher degree of antigenic variation than comparing *M. tuberculosis* species alone ([@evw279-B13]). In this context, it has been also demonstrated that epitope variability is higher in widely distributed L4 sublineages relative to those geographically restricted ([@evw279-B52]). Specifically, despite of antigen conservation, we identified single mutations in 51/852 epitopes of 27 antigenic proteins encoded by the core-genome of the MTBC species analyzed. In addition, double and even higher number of mutations were found in 9/852 epitopes of seven antigenic proteins. These polymorphisms are detailed in [fig. 6*B*](#evw279-F6){ref-type="fig"} and [supplementary table S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online.

Some polymorphisms are specific of one specie as the case of Ala71Ser in EsxH and Ala177Val in IlvB1, which are highly represented in *M. africanum*, and Thr46Pro in Mce4C of *M. bovis*. Others are conserved in different species such as Val352Ala in PstS1 and Gln68His in Rv1733c which are represented in *M. africanum*, *M. bovis*, *M. orygis*, *M. caprae*, and *M. tuberculosis* Beijing. The effect of some of these polymorphisms in antigenic proteins was partially investigated.

This is the case of EsxH, a short protein of 96 amino acids in length, which is a member of the Esx family (Uniprot P9WNK3; [@evw279-B31]). *M. tuberculosis* encodes 23 Esx proteins (EsxA--W), which are generally short in length (∼100 residues) and are organized in pairs within the genome. Of these, the EsxA/EsxB (ESAT-6/CFP10) pair is the best known mycobacterial virulence factor and promotes escape of *M. tuberculosis* from the phagosome to the cytosol ([@evw279-B60]; [@evw279-B30]) The EsxG/EsxH pair is co-ordinately regulated forming a small operon. Both proteins interact with each other to form a tight 1:1 complex ([@evw279-B34]). EsxG·EsxH complex contains a specific Zn(2+) binding site in the *N*-terminal.

The tridimensional structure of EsxG·EsxH complex has been resolved by NMR spectroscopy ([@evw279-B31]). The contact surface between EsxG and EsxH is essentially hydrophobic and the Ala71 residue is located in the intermolecular interface of EsxG·EsxH complex close to Met72, which together Met18 form the base of the cleft. The conserved substitution Ala71Ser in *M. africanum* probably destabilizes this hydrophobic interaction. The comparison of the native complex structure and that of the mutant Ala71Ser shows that the polar Ser71 residue perturbs the interface close to EsxG--Arg57 and EsxH--Met72 ([fig. 7](#evw279-F7){ref-type="fig"}). The adjacent conserved Ala71/Ser71 replacement could also perturb the metal binding. Thus, besides the potential role of these epitope polymorphisms in altering binding to MHC molecules (as will be studied below), mutations in these antigens might also impact on protein functionality.

![(*A*) Native and (*B*) mutated structures of the EsxG/EsxH (Rv0287/Rv0288) antigens (pdb 2kg7; [@evw279-B31]). The EsxG (yellow) and EsxH (blue) proteins are shown in ribbon. The amino acids Arg 57 of EsxG and Ala71/Ser71 and Met72 of EsxH are shown as spheres. The three-dimensional cartoons were drawn using PyMol 1.4.1 (Schrodinger LLC).](evw279f7p){#evw279-F7}

Other antigen carrying amino acid mutations is Rv0934 (Uniprot P9WGU1), which corresponds with the phosphate-binding protein PstS1 and functions in inorganic phosphate uptake ([@evw279-B45]). The tridimensional 2.16 Å structure of phosphate-bound PstS-1 has been resolved by X-ray crystallography ([@evw279-B62]). The residues Asn66 and Val352 are localized in the surface of the N-terminus (residues 42--128) and the C-terminus (residues 314--374) of the protein, respectively, which are exposed to the solvent ([supplementary fig. S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The substitution Asn66Ser can modify slightly the electrostatic surface of the protein as shown in [supplementary figure S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. This polymorphism might perturb the electrostatic balance and the interaction with the outer cell wall membrane and/or the capture of ligands as phosphate in the medium. The Val352Ala polymorphism has been reported earlier in *M. bovis* and BGC by [@evw279-B35]. It is worth noting that our analysis indicates that this substitution is also highly represented in other species such as *M. africanum*, *M. orygis*, and *M. caprae*. Because the mycobacterial antigen PstS1 is a highly immunogenic and immunostimulatory component of the mycobacterial cell membrane such mutation might be an evolutionary adaptation and have caused immune evasion ([@evw279-B35]).

Additionally, the 1.5 Å resolution structure of MPT63 (Rv1926c, Uniprot P9WIP1, pdb 1lmi) shows that the substitution Val93Ile found in *M. canettii* is localized in the only helical secondary structure, a 3~10~ helix of three residues at the start of β-strand 6 ([supplementary fig. S6](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). This position is in the vicinity of a negatively charged cavity and a positively charged channel, features probably with implications in the MPT63 function ([@evw279-B28]).

Effect of Epitope Polymorphisms on HLA Binding Calculated by Predictive Algorithms
----------------------------------------------------------------------------------

Binding of *Mycobacterium* epitopes to MHC class II molecules (named HLA in humans) plays a central role to mount an efficient adaptive immunity mediated by T-cells ([@evw279-B40]). Accordingly, polymorphisms in epitopes might alter the binding affinities of these molecules to the HLA cleft and the subsequent immune responses ([@evw279-B32]). Because HLA genes harbor a high degree of polymorphisms, testing the binding affinity of individual epitopes is challenging. Hence, *in silico* algorithms are useful prediction tools to compare the binding of epitope variants across representative HLA haplotypes. Using such immunoinformatics approach, we demonstrate that some epitope polymorphisms greatly impact the number of HLAs able to bind epitopes with high affinity. Consequently, because HLA molecules have distinct frequencies across the world, the fraction of the human population that will theoretically respond to the described epitopes (population coverage) can be affected ([@evw279-B10]). In our data, population coverage across several world regions was increased for Val34Met in Rv0288 (EsxH), Leu262Arg in Rv0290 (EccD3), Ile212Thr in Rv0853c (Pdc), Ala162Thr in Rv1733c, Val93Ile in Rv1926c (MPT63), Pro194Ser in Rv3714c, and Thr145Ala in Rv3804c (FbpA/Ag85A). On the other hand, a decrease was observed for Pro9Leu and Ala71Ser in Rv0288 (EsxH), diverse mutations in Rv2819c, Leu270Val in Rv3025c (IscS) and Leu76Arg in Rv3615c (EspC) ([fig. 8;](#evw279-F8){ref-type="fig"}[supplementary table S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Our results also suggest that T-cell vaccine design might benefit from taking into account MTBC strain variation and global HLA haplogroup distributions. Indeed, a polymorphism in Rv3804c (FbpA/Ag85A) found in a specific *M. africanum* strain results in stronger interaction of this epitope variant by most HLA haplogroups and specially in central American people ([fig. 8](#evw279-F8){ref-type="fig"}). Conversely, some epitope mutations cause little or no alteration in population coverage ([supplementary table S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Predictions for HLA class I binding was also performed ([supplementary table S5](#sup1){ref-type="supplementary-material"} and fig. S7, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

![*In silico* prediction of the interaction of epitopes with the main HLA class II haplotypes. Each graph represents the population coverage of HLA class II alleles predicted to bind specific epitope variants (*Y*-axis) across 15 geographic regions (*X*-axis). Population coverages for the *M. tuberculosis* H37Rv epitope are indicated by orange lines and population coverages for the mutant variants in other MTBC species are shown by blue lines.](evw279f8p){#evw279-F8}

Discussion
==========

According to the clonal origin of MTBC species, it is observed that mutations in coding sequences are uniformly distributed across the MTBC. The *M. canettii* outgroup has *ca.* 1.7 more mutations per protein than the average and this observation can be associated to its greater genetic diversity. Irrespective of this uniform distribution, proteins involved in lipid and respiration pathways have accumulated mutations during the MTBC evolution. During infection *M. tuberculosis* uses lipids (fatty acids and cholesterol) from the host macrophages as the main energy source ([@evw279-B49]; [@evw279-B48]). In this context, it is tempting to hypothesize that polymorphisms in the lipid metabolism might provide selective benefits to survive in the intracellular fatty acid environment. Those strains with efficient metabolic flux through lipid metabolism routes would be associated with higher virulence and *vice versa*. Concerning the higher frequency of polymorphisms of proteins involved in intermediary metabolism and respiration, TB-causing bacteria should be able to shift from an aerated environment during transmission to a hypoxic environment during infection. Accordingly, we can postulate that polymorphisms in respiration pathways might influence the infectious cycle. A recent study has linked the hypoxic response with lipid metabolism in *M. tuberculosis* ([@evw279-B26]) and consequently it is possible that both metabolic pathways have co-evolved in different *Mycobacterium* species.

The comparative analyses of protein variations carried out in this work point out that changes in flexibility/ductility of MTBC protein regions can explain phenotype differences. It is known that IDRs in proteins are relevant in molecular recognition and protein-protein interactions ([@evw279-B58]; [@evw279-B66]). This fact makes that these regions can have an important role in bacterial pathogenesis and virulence. A previous study demonstrated that a Gly71Ile substitution severely impacts on the functionality of PhoPR. The periplasmic loop of PhoR is involved in the recognition of a yet unknown activating stimulus. Accordingly, changes in ductility of the PhoR sensor domain might impair recognition of the activating stimulus which otherwise would result in lack of PhoP transcriptional activation of virulence genes ([@evw279-B9]). It is important to remember that the Gly71Ile substitution is exclusive of *M. africanum* and animal-adapted *Mycobacterium* species. These lineages are associated with slower progression to active disease and lower pathogenicity in humans than the human-adapted pathogen *M. tuberculosis* ([@evw279-B27]). In line with this observation, A.K. Dunker and co-workers have reported that evolution of disordered regions can be related to pathogenic microbes in comparison with non-pathogenic ones ([@evw279-B39]). Altogether, it is worth noting that this structural analysis provides the first relationship between such protein structural variation and reported phenotype differences.

Here, we also demonstrate that hyperconservation of T-cell epitopes can be extrapolated to the whole MTBC. Accordingly, we can assume that human-adapted lineages (*M. tuberculosis* L1--L4 and L7 and *M. africanum* L5 and L6) equally benefit from being recognized by the human immune system. This finding could be also applied to the zoonotic transmission of *M. bovis* from cattle to humans, because our results demonstrate hyperconservation of human epitopes in the cow pathogen *M. bovis*. However, because we do not know the epitope repertoire in mammalian hosts infected by animal-adapted species, we cannot confirm whether animal T-cell epitopes are also evolutionarily hyperconserved.

Interestingly, despite epitopes are hyperconserved some of them show mutations. These variations could affect the structure and function of their corresponding antigens such is the case of EsxH. A recent study has demonstrated that EsxH is required for proper iron acquisition in *M. tuberculosis* and deletion of *esxH* results in decreased virulence in mice ([@evw279-B56]). Because a similar mutation has been reported in the non MTBC species *M. marinum* and *M. ulcerans*, it might represent an evolutionary adaptation of these species to modulate iron availability and/or virulence to specific hosts.

It is also worth of mentioning that mutations found in epitopes are predicted to modify the binding affinity to HLA proteins. A recent study expanded the search for antigenic variations by examining 1226 epitopes in 216 diverse strains of *M. tuberculosis*. Seven antigenic proteins showed amino acid changes between *M. tuberculosis* lineages. Epitopes of these proteins were immunogenic in whole blood assays and importantly, amino acid mutations in these epitopes produced differential immune stimulation ([@evw279-B16]). Another recent study demonstrated differences in dN/dS of epitopes from L4 sublineages. Those sublineages considered generalists associated with worldwide distribution present higher epitope variation than geographically restricted specialist sublineages ([@evw279-B52]).These pioneering studies have paved the way to study rare epitope variants and our findings could help to translate this knowledge to other MTBC species that are also an important cause of mortality in animals and restricted human populations. In this regard, a Leu262Arg in EccD3 of *M. bovis* found in this work greatly increases the population coverage of HLAs class II that theoretically respond to this epitope. It remains to be explored whether this polymorphism is associated to more efficacious zoonotic transmission of certain *M. bovis* strains. Different polymorphisms in Rv0288 (EsxH) from *M. africanum* are associated with higher (Val34Met) and lower (Pro9Leu and Ala71Ser) human population coverages of HLAs class II responding to these variants. These might be sites involved in the adaption of the different species to humans or to specific subsets of the human population.

Finally, even if immunogenicity does not necessarily correlate with protection, our results could have extraordinary implications in vaccine development. Future vaccine candidates might greatly benefit from containing epitope variants with increased potential to stimulate immunity. This could be applied to either live attenuated vaccines constructed in genetically immunodominant backgrounds or to subunit vaccines containing antigens with immunodominant epitopes. One of the most advanced vaccine candidates named MVA85A consist on the Modified Vaccinia Ankara virus expressing FbpA/Ag85A. This vaccine was designed to boost the immunity provided by BCG. Although MVA85A was safe and immunogenic it failed to confer significant protection compared with BCG ([@evw279-B54]). Our predictions indicate that FbpA/Ag85A variant found in *M. africanum* binds with more affinity to most HLA haplogroups. If this FbpA/Ag85A variant proves to be differentially immunogenic comparatively to the wild type, new vaccines based on modified MVA85A could be efficacious strategies to combat TB. Currently, 4 of 8 subunit vaccines (Ad5Ag85A, ChAdOx185A, MVA85A, and TB/FLU-04L) contain Ag85A expressed from a viral vector. Other subunit vaccines use FbpB/Ag85B, a related member to the Fbp family ([@evw279-B24]). Because there is a dominance of vaccines that express or contains Fbp proteins, these strategies could greatly benefit from comparative and immunological studies to select the best antigenic variants.
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